Late Stage Mature Pre IPO Unicorns - PreIPOSwap.com
IPO

23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics

From PR NewsWire: – 23andMe is a leading consumer genetics and research company that offers a personalized health and wellness experience, and has built a premier genetic database to unlock insights leading to the rapid discovery of promising new targets for drug development – Transaction will provide the capital to fund additional investment in key[…]

23andMe evolved into a genetic biotech powerhouse

From Zero Hedge: What started out as a genetic ancestry company has transformed into what can only be called a biotech.  Before digging into what’s going on now we need to preface this with a bit of history.  In a story broke on the site you are reading now  (Zero Hedge), 23andMe (and other firms) was caught giving[…]